Globus Medical (NYSE: GMED) reported Q4 EPS of $0.39, $0.09 better than the analyst estimate of $0.30. Revenue for the quarter came in at $142.6 million versus the consensus estimate of $141.2 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.